Biostatistical Methods for Clinical Research III
BIOSTAT 209 Spring 2019 (3 units)
This is the third course in the TICR Program biostatistics sequence, covering multi-predictor variable methods in the context of survival analysis and repeated measures analysis. Emphasis is on the practical and proper use of statistical methodology and its interpretation. The statistics package STATA will be used throughout the course.
At the end of the course, students will be able to:
All course materials and handouts will be posted on the course's online syllabus.
Regression Methods in Biostatistics by Vittinghoff, Glidden, McCulloch, and Shiboski. Springer, 2012.
Stata Statistical Software (Stata Corporation, College Station, TX) will be used; version 13 will suffice for more than 95% of the course content and that a student can pass the course without upgrading to higher versions. A six-month student license for Stata/IC is the least expensive option that will be suitable to complete all course assignments, but Stata/SE is recommended for robust future use. The TICR Program has arranged for a discount for UCSF-affiliated personnel.
Books may be purchased either through the publisher or a variety of commercial venues (e.g., Amazon.com).
Grades will be based on 5 homework assignments (70%) and a data analysis project (30%). Late work is not accepted.
Information about project requirements can be found here.
Students not in full-year TICR Programs who satisfactorily pass all course requirements will, upon request, receive a Certificate of Course Completion.
This course is sponsored by the Training in Clinical Research (TICR) Program, and space is limited. Preference is given to UCSF-affiliated personnel. We regret that auditing is not permitted.
To apply for this course, please fill out and submit the application below. Please see our fees page for cost information. The deadline for application is March 22, 2019. Only one application needs to be completed for all courses desired during the quarter.
The application is best completed using the latest version of Firefox, Chrome or Safari.